CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
CPAP and room airdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02249143
NCT02249143N/ACompleted

Duration of Continuous Positive Airway Pressure and Pulmonary Function Testing in Preterm Infants

Oregon Health and Science University·interventional·Posted Sep 25, 2014·Updated Aug 29, 2019

In Brief

A clinical study evaluating CPAP and room air for Respiratory Distress Syndrome and Bronchopulmonary Dysplasia. Completed, enrolled 50 participants across 1 site.

Detailed Summary

The primary aim of this study is to quantify and compare changes in lung volumes (as measured by functional residual capacity) in premature infants stable on continuous positive airway pressure (CPAP), and then randomized to two additional weeks of CPAP and room air versus room air alone. We hypothesize that infants randomized to additional CPAP will demonstrate an increased functional residual capacity (at the end of the two week study period and prior to discharge) compared to those randomized to room air.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 25, 2014
Enrollment StartSep 1, 2014
Primary CompletionMay 1, 2016
Study CompletionSep 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 11.8 years ago

Interventions

CPAP and room airdevice

Stable premature infants on CPAP and room air and meeting specific stability criteria will be randomized to stay on continuous positive airway pressure and room air for an additional two weeks or will be transitioned to room air alone.